Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

909.15 +3.02 (+0.33%)
Official Closing Price Updated: 7:00 PM EDT, Oct 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,392,179
Open 901.67
Bid (Size) 907.00 (1)
Ask (Size) 911.00 (1)
Prev. Close 906.13
Today's Range 900.20 - 911.12
52wk Range 547.61 - 972.53
Shares Outstanding N/A
Dividend Yield 0.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
Viking Therapeutics (VKTX) set to report Q3 earnings amid high expectations, thanks to promising weight-loss drug candidate. Stock up 240% YTD. 
Via Benzinga
Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises
The activist investor says Pfizer has underperformed its peers and the broader market since 2019. 
Via Investor's Business Daily

Performance

YTD
+53.52%
+53.52%
1 Month
-1.02%
-1.02%
3 Month
+3.51%
+3.51%
6 Month
+21.92%
+21.92%
1 Year
+57.66%
+57.66%

More News

Read More
Eli Lilly Sues Some Vendors For Unauthorized Sale Of Fake Weight-Loss Drug
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
1 Reason to Buy Eli Lilly Stock Hand Over Fist Right Now
Via The Motley Fool
Investing $10,000 in Each of These 3 Stocks 10 Years Ago Would Have Made You $1.1 Million
Via The Motley Fool
Behind the Scenes of Eli Lilly's Latest Options Trends
Via Benzinga
Investigating Eli Lilly's Standing In Pharmaceuticals Industry Compared To Competitors
Via Benzinga
$1000 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today
Via Benzinga
AskSlim Market Week - Friday, Oct. 19
Via Talk Markets
Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
Via Investor's Business Daily
2 High-Flying Growth Stocks With Massive Upside Potential
Via The Motley Fool
This is Huge News For Eli Lilly Investors
Via The Motley Fool
Exploring NYSE:LLY's high growth characteristics.
Via Chartmill
3 Reasons Eli Lilly Stock Isn't Going to Run out of Steam Anytime Soon
Via The Motley Fool
Eli Lilly Unusual Options Activity
Via Benzinga
Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk.
Via Investor's Business Daily
Exposures Product Safety
This Artificial Intelligence Move Is One New Reason to Buy Eli Lilly Stock in 2024
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?
Via The Motley Fool
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
Via The Motley Fool
Exposures Product Safety
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
Via Benzinga
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
Via Talk Markets
Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe
Via Benzinga
Hims & Hers Health Stock Is Popping Monday: What's Behind The Move?
Via Benzinga
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
Via Investor's Business Daily
Topics Lawsuit
Exposures Financial Legal Product Safety
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.